Skip to main content

St. Louis startup developing cancer-fighting drug raises $21M

The St. Louis biotechnology startup plans to use its new funding to advance clinical trials of its lead drug candidate.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.